Sponsor or institution
Clinical trials and research at Tarn Biosciences, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $581,148 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Nitroreductase-activated inhibitors to treat mycobacterial infections
A patient-friendly program to develop new nitroreductase-activated drugs for treating drug-susceptible and drug-resistant tuberculosis and non-tuberculous mycobacterial infections.
-
Developing a new treatment for tuberculosis using MmpL3 inhibitors
This study is testing a new medication called HC2099 to help treat tuberculosis, especially the tougher drug-resistant types, by targeting a key protein that the TB bacteria need to survive, with the hope of making treatment easier and more effective for patients.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.